Skip to main content
Menu
Revvity logo
Contact us
US
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Login/Register here
Revvity web shop online account

Get exclusive pricing on all online purchases.

Login to your Revvity.com account for your account's pricing, easy re-ordering from favorites & order history, priority order processing, and dynamic order tracking.

Login Register
Revvity Omics portal accounts

Initiate a new order or access test status and results for clinical genomics or newborn screening services.

View login options
Breadcrumb
...
  • Home
  • Products
  • Clinical & Diagnostics
    • Research & Development
    • Clinical & Diagnostics
    • Reagents
    • Platforms & Automation
    • Consumables & Accessories
    • Signals Software
    • Revvity Omics Services
  • Infectious Diseases
    • Reproductive Health
    • Infectious Diseases
    • Cancer
    • Autoimmunity
    • Endocrinology
    • Allergy
    • Neurodegeneration
    • Rapid Patient Testing
infection-disease-hero1077x606

Infectious Diseases

Infectious diseases are disorders caused by organisms, such as viruses, bacteria, parasites or fungi and can be passed from person to person, transmitted by insects or other animals.

We offer a diverse portfolio of clinical and research solutions that help healthcare providers, laboratorians and scientists make critical decisions and discoveries.

Our clinical solutions include a wide range of infectious disease serology, immunoassays and selected PCR-based direct detection assays to assess acute and ongoing infections, or to follow progression of the disease to evaluate the immune status:
 

  • Pregnancy-relevant 
  • Childhood communicable 
  • Congenital 
  • Gastrointestinal 
  • Respiratory 
  • Sexually transmitted 
  • Vaccine preventable 
  • Vector borne 
  • Emerging diseases 
  • …and more


Our research solutions include genomic analysis, in vitro, cell-based, and in vivo studies.

cell-painting-thubnail_512x288.jpg

Explore our clinical solutions

L3Page-2 EUROIMMUN_344x194.jpg

EUROIMMUN Solutions

We offer diagnostic solutions for the detection of various well-known and rare viral, bacterial or parasitic infections for streamlined laboratory workflows.

Learn more
ids allergy solutions.jpeg

IDS Solutions

IDS provides automated testing solutions for specialty infectious diseases and aid in assessing the immune status of a patient with reference to a specific infection.

Learn more
T cell immunology

T-SPOT Technology

The immune system is a complex network of cells and proteins that defend the body against infection. Key cells like T cells, B cells, macrophages, dendritic cells and neutrophils work together to identify, eliminate, and neutralize pathogens.
Learn more
L4P4-Nucleic-Acid-Isolation-for-Pathogen-Detection-512x288-Thumbnail.jpg

Nucleic Acid Isolation for Pathogen Detection

Revvity offers the extraction of DNA and RNA from a variety of microorganisms, including viruses, bacteria, and fungi, found in sample materials like blood, plasma, stool, and swabs.
Learn more
sars-cov-2-testing-solutions-thumbnail

SARS-COV-2 Testing Solutions

We are here to help laboratories overcome their COVID testing challenges so they can better address the world’s public health concerns.
Learn more | Shop now
Tulip solutions_344x194.jpg

Tulip Solutions

Leading Indian diagnostic company involved in the manufacture and marketing of in-vitro diagnostic reagents and kits to clinical labs.

Learn more
tb-management-thumbnail-512x288

Tuberculosis Management

Learn about TB, its impact, and the importance of accurately detecting latent infections using advanced IGRA tests for effective TB management.

Learn more
View all View less

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability

Explore our research solutions

viral512x288

Bacterial & Viral Nucleic Acid Isolation

Revvity offers reliable, automated solutions for microbial nucleic acid isolation from challenging sample material such as wastewater, soil, bacterial cultures, stool, murine gut, and ticks.
Learn more
qpcr

qPCR

Quantitative (qPCR) is ideal for the detection of bacteria and viruses due to its ability to accommodate a broad range of concentrations of targets in a single well
Learn more
metagenomics-thumbnail

Metagenomics

Revvity’s streamlined, automated workflow from DNA extraction to sequence ready libraries for 16S and shotgun sequencing resulting in robust data for species identification and functional profiling.
Learn more
View all View less

For research use only. Not for use in diagnostic procedures. 
 

infection-disease-hero1077x606

Investigator Led Studies at Revvity

We are committed to improving the care of patients with immune-regulated conditions by providing funding and other forms of support to qualified investigators who share our commitment and work within our areas of interest.

Learn more

Featured Blogs

img-blog-feature-tile-on-tb-landing-page-512x288.png
World tuberculosis day 2025: Raising awareness to support global TB control efforts.

Explore the latest global TB trends, challenges, and breakthroughs on World Tuberculosis Day. Learn how innovative diagnostics are shaping the fight against TB.

viral-cytopathic512x288
Taking advantage of viral cytopathic effects to aid in the rapid screening of effective viral therapies.

Taking Advantage of Viral Cytopathic Effects to Aid in the Rapid Screening of Effective Viral Therapies

sirna 512x288
High-content imaging siRNA screens identify trafficking factors in Alphavirus infection.

The complex relationship between a virus and its host is one of the hottest topics in science right now, and has been given considerable attention in recent weeks as a result of the race to understand the virus that causes COVID-19 and its potential vulnerabilities.

covid-19
Now we have a COVID-19 vaccine, are treatments really needed.

When the World Health Organization declared the COVID-19 outbreak a pandemic in March 2020, it was clear that the novel coronavirus posed a significant threat to global health.

visualizing-sars-cov
Visualizing SARS-CoV-2 interactions in 3D.

Since the first reported case of COVID-19 in December 2019, researchers around the world have been working to improve their understanding of the novel coronavirus, SARS-CoV-2.

rethinking-how-we
Rethinking how we prepare for the next pandemic.

The SARS-CoV-2 pandemic has highlighted the fundamental role that research and innovation play in protecting people from the potential deadly effects of infectious diseases

engineered-viral-hero
Now we have a COVID-19 vaccine, are treatments really needed.

When the World Health Organization declared the COVID-19 outbreak a pandemic in March 2020, it was clear that the novel coronavirus posed a significant threat to global health. Little was known about how the virus spread, who the disease affected most, and how to best prevent transmission.

How a SARS-CoV-2 infection can impact our reproductive health
How a SARS-CoV-2 infection can impact our reproductive health.

This article describes the short and long-term impact of SARS-CoV-2 infection on male reproductive health based on two studies carried out in Belgium.

line

How can we help you?

We are here to answer your questions.

Contact us
Contact us
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.